ArticleInternational journal of molecular sciences2019

Liraglutide Inhibits Hepatitis C Virus Replication Through an AMP Activated Protein Kinase Dependent Mechanism.

Mei-Yueh Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.